RENBP Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P51606 |
---|---|
Clone Names | 100318177 |
Gene ID | 5973 |
---|---|
Other Names | N-acylglucosamine 2-epimerase, AGE, GlcNAc 2-epimerase, N-acetyl-D-glucosamine 2-epimerase, Renin-binding protein, RnBP, RENBP |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | RENBP |
---|---|
Function | Catalyzes the interconversion of N-acetylglucosamine to N- acetylmannosamine (PubMed:9990133, PubMed:10502668, PubMed:12499362). Involved in the N-glycolylneuraminic acid (Neu5Gc) degradation pathway: although human is not able to catalyze formation of Neu5Gc due to the inactive CMAHP enzyme, Neu5Gc is present in food and must be degraded (PubMed:9990133). |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The gene product inhibits renin activity by forming adimer with renin, a complex known as high molecular weight renin.The encoded protein contains a leucine zipper domain, which isessential for its dimerization with renin. The gene product cancatalyze the interconversion of N-acetylglucosamine toN-acetylmannosamine, indicating that it is a GlcNAc 2-epimerase.Transcript variants utilizing alternative promoters have beendescribed in the literature.
References
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Gu, D., et al. J. Hypertens. 28(6):1210-1220(2010)Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009)Luchansky, S.J., et al. J. Biol. Chem. 278(10):8035-8042(2003)Bohlmeyer, T., et al. J. Card. Fail. 9(1):59-68(2003)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.